VEGF receptor binding peptide-linked high mobility box group-1 box A as a targeting gene carrier for hypoxic endothelial cells

Journal of Cellular Biochemistry

Volumn 110, Issue 5, 2010, Pages 1094-1100

  Han, Jee Seung ^a   Kim, Hyun Ah ^a   Lee, Sanghyun ^a   Lee, Minhyung ^a  

^a Hanyang University   (South Korea)

Author keywords

Endothelial cells; Gene delivery; High mobility group box 1; Hypoxia; Plasmid

Indexed keywords

BINDING PROTEIN; CHELATING AGENT; HIGH MOBILITY GROUP B1 PROTEIN; LUCIFERASE; NICKEL COMPLEX; POLYLYSINE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR BINDING PEPTIDE; VASCULOTROPIN RECEPTOR BINDING PEPTIDE HIGH MOBILITY GROUP B1 PROTEIN COMPLEX;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; CANCER GENE THERAPY; CELL HYPOXIA; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; GENE VECTOR; GENETIC TRANSFECTION; HYPOXIA; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PULMONARY ARTERY; SOLID TUMOR;

ANIMALS; BINDING SITES; CELL HYPOXIA; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE TRANSFER TECHNIQUES; HMGB1 PROTEIN; HUMANS; PEPTIDES; PLASMIDS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TRANSFECTION;

EID: 77954950795     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22621     Document Type: Article

References (31)

1. Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ. 2002. HMGB1 as a DNA-binding cytokine. J Leukoc Biol 72:1084-1091.
2. Balicki D, Reisfeld RA, Pertl U, Beutler E, Lode HN. 2000. Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma. Proc Natl Acad Sci USA 97:11500-11504.
3. Balicki D, Putnam CD, Scaria PV, Beutler E. 2002. Structure and function correlation in histone H2A peptide-mediated gene transfer. Proc Natl Acad Sci USA 99:7467-7471. (Pubitemid 34568714)
4. Benns JM, Choi JS, Mahato RI, Park JS, Kim SW. 2000. pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly(L-histidine)-graft-poly(L- lysine) comb shaped polymer. Bioconjug Chem 11:637-645.
5. Benns JM, Maheshwari A, Furgeson DY, Mahato RI, Kim SW. 2001. Folate-PEG-folate-graft-polyethylenimine-based gene delivery. J Drug Target 9:123-139.
6. Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, Isner JM. 1996. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 97:469-476. (Pubitemid 26039412)
7. Carmeliet P. 2005. Angiogenesis in life, disease and medicine. Nature 438:932-936.
8. El-Mousawi M, Tchistiakova L, Yurchenko L, Pietrzynski G, Moreno M, Stanimirovic D, Ahmad D, Alakhov V. 2003. A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library. J Biol Chem 278:46681-46691.
9. Fajac I, Allo JC, Souil E, Merten M, Pichon C, Figarella C, Monsigny M, Briand P, Midoux P. 2000. Histidylated polylysine as a synthetic vector for gene transfer into immortalized cystic fibrosis airway surface and airway gland serous cells. J Gene Med 2:368-378.
10. Fischer D, Bieber T, Li Y, Elsasser HP, Kissel T. 1999. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: Effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 16:1273-1279. (Pubitemid 29393618)
11. Folkman J, Kalluri R. 2004. Cancer without disease. Nature 427:787.
12. Gale NW, Thurston G, Davis S, Wiegand SJ, Holash J, Rudge JS, Yancopoulos GD. 2002. Complementary and coordinated roles of the VEGFs and angiopoietins during normal and pathologic vascular formation. Cold Spring Harb Symp Quant Biol 67:267-273. (Pubitemid 36775520)
13. Han S, Mahato RI, Sung YK, Kim SW. 2000. Development of biomaterials for gene therapy. Mol Ther 2:302-317.
14. Han JS, Kim K, Lee M. 2009. A high mobility group B-1 box A peptide combined with an artery wall binding peptide targets delivery of nucleic acids to smooth muscle cells. J Cell Biochem 107:163-170.
15. Hemmerlein B, Kugler A, Ozisik R, Ringert RH, Radzun HJ, Thelen P. 2001. Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas. Virchows Arch 439:645-652. (Pubitemid 33071203)
16. Kang HC, Lee M, Bae YH. 2005. Polymeric gene carriers. Crit Rev Eukaryot Gene Expr 15:317-342.
17. Kaouass M, Beaulieu R, Balicki D. 2006. Histonefection: Novel and potent non-viral gene delivery. J Control Release 113:245-254. (Pubitemid 43983040)
18. Kim K, Han JS, Kim HA, Lee M. 2008a. Expression, purification and characterization of TAT-high mobility group box-1A peptide as a carrier of nucleic acids. Biotechnol Lett 30:1331-1337.
19. Kim K, Han JS, Park JH, Ko KS, Lee M. 2008b. Expression and characterization of a recombinant high mobility group box 1 AB peptide with a 6-histidine tag for delivery of nucleic acids. Enzyme Microbial Technol 43:410-416.
20. Komi Y, Ohno O, Suzuki Y, Shimamura M, Shimokado K, Umezawa K, Kojima S. 2007. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin. Jpn J Clin Oncol 37:867-873. (Pubitemid 350259006)
21. Lee M, Nah JW, Kwon Y, Koh JJ, Ko KS, Kim SW. 2001. Water-soluble and low molecular weight chitosan-based plasmid DNA delivery. Pharm Res 18:427-431. (Pubitemid 32592572)
22. Li J, Kokkola R, Tabibzadeh S, Yang R, Ochani M, Qiang X, Harris HE, Czura CJ, Wang H, Ulloa L, Warren HS, Moldawer LL, Fink MP, Andersson U, Tracey KJ, Yang H. 2003. Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med 9:37-45.
23. Puebla I, Esseghir S, Mortlock A, Brown A, Crisanti A, Low W. 2003. A recombinant H1 histone-based system for efficient delivery of nucleic acids. J Biotechnol 105:215-226. (Pubitemid 37315764)
24. Semenza GL, Agani F, Feldser D, Iyer N, Kotch L, Laughner E, Yu A. 2000. Hypoxia, HIF-1, and the pathophysiology of common human diseases. Adv Exp Med Biol 475:123-130. (Pubitemid 32197719)
25. Sloots A, Wels WS. 2005. Recombinant derivatives of the human high-mobility group protein HMGB2 mediate efficient nonviral gene delivery. FEBS J 272:4221-4236. (Pubitemid 41160928)
26. Stott K, Tang GS, Lee KB, Thomas JO. 2006. Structure of a complex of tandem HMG boxes and DNA. J Mol Biol 360:90-104. (Pubitemid 43927811)
27. Thomas JO. 2001. HMG1 and 2: Architectural DNA-binding proteins. Biochem Soc Trans 29:395-401.
28. Vincent KA, Shyu KG, Luo Y, Magner M, Tio RA, Jiang C, Goldberg MA, Akita GY, Gregory RJ, Isner JM. 2000. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation 102:2255-2261.
29. Wu Q, Zhang W, Pwee KH, Kumar PP. 2003. Rice HMGB1 protein recognizes DNA structures and bends DNA efficiently. Arch Biochem Biophys 411:105-111.
30. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. 2000. Vascular-specific growth factors and blood vessel formation. Nature 407:242-248.
31. Yoshioka K, Saito K, Tanabe T, Yamamoto A, Ando Y, Nakamura Y, Shirakawa H, Yoshida M. 1999. Differences in DNA recognition and conformational change activity between boxes A and B in HMG2 protein. Biochemistry 38:589-595.